Biotech ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director July 5, 2022
Biotech Chinook Therapeutics Receives Orphan Drug Designation from European Commission for BION-1301 for Treatment of Primary IgA Nephropathy (IgAN) July 5, 2022
Biotech Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 5, 2022
Biotech Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2022 July 5, 2022
Biotech BioCryst Presents New Data Demonstrating Consistently Low Attack Rates Among HAE Patients After Switching to ORLADEYO® (berotralstat) July 1, 2022
Biotech BioCryst Presents New Data Demonstrating Consistently Low Attack Rates Among HAE Patients After Switching to ORLADEYO® (berotralstat) July 1, 2022